Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BIOMAX NORGE AS
AS
Active
Org 927500914
Ryggeveien 157, 1570 Dilling
Rørleggerarbeid · NACE 43221
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 11K
-84% vs 2022
EBITDA margin
-1660.7%
+41% vs 2022
Equity ratio
-2424.9%
Financial strength
Net profit 2023
NOK -185K
+41% vs 2022
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
NOK 11K
-84%
EBITDA
NOK -185K
+41%
Net profit
NOK -185K
+41%
Total assets
NOK 24K
-83%
Equity
NOK -576K
-47%
Employees
1
—
Company information
Legal name
BIOMAX NORGE AS
Org number
927500914
Legal form
Aksjeselskap
NACE code
43221 · Rørleggerarbeid
Founded
4. august 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Import, salg, montering, service av bio rense anlegg.
Contact
Address
Ryggeveien 157, 1570 Dilling
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Rørleggerarbeid
Companies in Moss
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
Income statement
NOK thousands
Item
2021
2022
2023
Revenue
0
70
11
Staff expenses
−92
−105
−39
EBITDA
−108
−313
−185
Depreciation & amort.
−0
−0
−0
EBIT
−108
−313
−185
Net financials
0
0
0
Profit before tax
−108
−313
−185
Tax
−0
−0
−0
Net profit
−108
−313
−185
Balance sheet
NOK thousands
Item
2021
2022
2023
Total assets
16
137
24
Equity
−78
−391
−576
Long-term debt
0
302
94
Short-term debt
94
226
506
Total debt
94
528
600
Financial ratios
5-year trend
EBITDA margin
-1660.7%
This company
15.8%
Market median
-10611% vs market
2021
2023
Equity ratio
-2424.9%
This company
38.2%
Market median
-6448% vs market
2021
2023
Return on equity
-18486200.0%
This company
18.4%
Market median
-100468578% vs market
2021
2023
Net profit margin
-1658.6%
This company
8.1%
Market median
-20577% vs market
2021
2023
Asset turnover
0.47×
This company
1.12×
Market median
-58% vs market
2021
2023
Debt / equity
1.04×
This company
0.62×
Market median
-68% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AM
Arild Mangor Samuelsen
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
DO
Dainius Okunevas
Chairman
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Daido Holding As
Company
75%
75%
2024
AMBRO TRADING AS
Company
35%
35%
2023
Uab Hg Plastic
Company
15%
15%
2024
Nikolai David Brinkmann Berntsen
Individual
10%
10%
2024
Unknown
Individual
10%
10%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BIOMAX NORGE AS also hold positions in
0
other companies.
Person
Role here
Other companies
Arild Mangor Samuelsen
Chief Executive Officer
0 companies
Dainius Okunevas
Chairman
0 companies